Structural Interventional Cardiologist and Investigator @weillcornell | @nyphospital | @crfheart. Trained and formerly @columbiamed. Tweets are my own.
A major milestone for the P5 OPTIMAL trial: the first patients have now been randomized in the U.S.
P5 is exploring a new paradigm for the assessment and management of coronary calcium before complex PCI, using #CCTA to guide treatment planning and calcium modification strategies.
Congratulations to the Minneapolis Heart Institute @MHIF_Heart, @yadersandoval@ManosBR and team for becoming our first U.S. enrolling site and for being at the forefront of innovation and clinical care.
@jcspratt@crfheart@Heartflow@ShockwaveIVL@GEHealthCare
#PCI #CoronaryCalcium #CardiacCT #CCTA
Great #innovation session to close out #NYValves2026. Possible novel treatment option for LVAD patients with AR but further study is ongoing and needed. @crfheart@TCTMD
A TAVR system could work as a last resort for patients with LVAD-associated aortic regurgitation, according to a retrospective study. @crfheart@MVMadhavanMD#NYValves2026
https://t.co/Dv9iaRnLgp
What an informative session! We continue to learn from eachothers’ experience regarding patient selection- whom to treat remains a challenging decision sometimes. One size does not fit all and tailored approaches to individual patients are critical.
Watch Firas Zhar and @MVMadhavanMD recap all the exciting events from Day 1 of #NYValves2026, from Jersey Day to the opening session. https://t.co/dlSFwpKS4Z
Watch Firas Zhar and @MVMadhavanMD recap all the exciting events from Day 1 of #NYValves2026, from Jersey Day to the opening session. https://t.co/dlSFwpKS4Z